News | HIMSS | July 01, 2021

HIMSS21 is a COVID-19 Vaccination Required Event for all attendees, exhibitors and HIMSS staff

HIMSS21 is a COVID-19 Vaccination Required Event for all attendees, exhibitors, and HIMSS staff

Getty Images


July 1, 2021 — If you are traveling to HIMSS21 in August, be sure to note that the Healthcare Information and Management Systems Society (HIMSS) has adopted a “Vaccination Required” approach for all attendees, exhibitors and HIMSS staff at HIMSS21. This means all HIMSS21 attendees, exhibitors and HIMSS staff will have to provide proof of their COVID-19 “full vaccination” in order to gain access to the HIMSS21 campus. Per the HIMSS21 web site, a person is considered fully vaccinated:

  • 2 weeks after their second dose in a 2-dose series, such as the Pfizer and Moderna vaccines, or
  • 2 weeks after a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine

This guidance applies to COVID-19 vaccines authorized for emergency use by the U.S. Food and Drug Administration (Pfizer-BioNTech, Moderna, and Johnson and Johnson (J&J)/Janssen COVID-19 vaccines), and COVID-19 vaccines authorized for emergency use by the World Health Organization (AstraZeneca/Oxford, Covishield, Sinopharm and Sinovac), on or before July 26, 2021. The full list of vaccines with final WHO EUL/PQ evaluation status is available here.

If an attendee, exhibitor or HIMSS staff member does not meet these requirements, they are NOT considered fully vaccinated and will not be permitted to enter the HIMSS21 campus.

Masks will be supported but not required on the HIMSS21 campus. Because all attendees, exhibitors, and HIMSS staff must comply with the Right of Entry requirement, registrants will not be required to wear masks on campus.

For more information: www.himss.org


Related Content

News | Artificial Intelligence

September 25, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced ...

Time September 25, 2023
arrow
Feature | Magnetic Resonance Imaging (MRI) | Robert L. Bard, MD, and Lennard M. Gettz, EdD

Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...

Time September 25, 2023
arrow
News | Digital Pathology

September 22, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

Time September 22, 2023
arrow
Feature | Artificial Intelligence | By Melinda Taschetta-Millane

Jesse Ehrenfeld, MD, MPh, FAMIA, FASA, FCPP, president of the American Medical Association (AMA), addressed the topic of ...

Time September 22, 2023
arrow
News | Cardiac Imaging

September 21, 2023 — Declines in cardiovascular procedure volumes observed early in the COVID-19 pandemic greatly ...

Time September 21, 2023
arrow
News | X-Ray

September 21, 2023 — Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT ...

Time September 21, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
News | Enterprise Imaging

September 20, 2023 — aycan, a recognized leader in medical imaging, announced today a new solution for reviewing DICOM ...

Time September 20, 2023
arrow
Feature | Radiation Dose Management | By Melinda Taschetta-Millane

Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ...

Time September 20, 2023
arrow
Feature | Ultrasound Imaging | By Mustafa Hassan, PhD

Handheld ultrasound has not yet reached mainstream adoption, but the market is still forecast to reach over $500 million ...

Time September 20, 2023
arrow
Subscribe Now